Dysregulated emotional behavior occurs often in adults with ADHD. Analysis of clinical trials may guide clinical intervention and future research.
Method:
Controlled trials of adult ADHD measuring emotional behavior were included if another study offered a comparable analysis of the same treatment method. Standardized Mean Difference (SMD) of effects were calculated, and the size of effects for emotional and non-emotional ADHD behavior were compared.
Results:
13 out of 14 studies of methylphenidate, atomoxetine, and lisdexamfetamine demonstrated significant improvement in emotional behavior measures, with small to high SMDs. The proportional effect on emotional versus non-emotional behavior ranged from 46% to 110% for methylphenidate, 56% to 129% for atomoxetine, and 36% to 96% for lisdexamfetamine.
Conclusion:
Psychopharmacological treatments for ADHD are likely to improve emotional behavior, and available scales are sensitive to these effects. Studies dedicated to treatment of this domain of function can further refine clinical approaches.
AdlerL.TanakaY.WilliamsD.TrzepaczP. T.GotoT.AllenA. J.EscobarR.UpadhyayaH. P. (2014). Executive function in adults with attention-deficit/hyperactivity disorder during treatment with atomoxetine in a randomized, placebo-controlled, withdrawal study. Journal of Clinical Psychopharmacology, 34(4), 461–466. https://doi.org/10.1097/JCP.0000000000000138
2.
AdlerL. A.DirksB.DeasP. F.RaychaudhuriA.DauphinM. R.LasserR. A.WeislerR. H. (2013). Lisdexamfetamine dimesylate in adults with attention-deficit/ hyperactivity disorder who report clinically significant impairment in executive function: Results from a randomized, double-blind, placebo-controlled study. Journal of Clinical Psychiatry, 74(7), 694–702. https://doi.org/10.4088/JCP.12m08144
3.
BachmannK.LamA. P.SorosP.KanatM.HoxhajE.MatthiesS.FeigeB.MullerH.OzyurtJ.ThielC. M.PhilipsenA. (2018). Effects of mindfulness and psychoeducation on working memory in adult ADHD: A randomised, controlled fMRI study. Behaviour Research and Therapy, 106, 47–56. https://doi.org/10.1016/j.brat.2018.05.002
4.
BarkleyR. A. (1997). Behavioral inhibition, sustained attention, and executive functions: Constructing a unifying theory of ADHD. Psychological Bulletin, 121(1), 65–94.
5.
BarkleyR. A.MurphyK. R.FischerM. (2010). ADHD in adults: What the science says. Guilford press.
6.
BiedermanJ.MickE.FriedR.WilnerN.SpencerT. J.FaraoneS. V. (2011). Are stimulants effective in the treatment of executive function deficits? Results from a randomized double blind study of OROS-methylphenidate in adults with ADHD. European Neuropsychopharmacology, 21(7), 508–515. https://doi.org/10.1016/j.euroneuro.2010.11.005
7.
BrownT. E. (1996). Brown attention-deficit disorder scales: For adolescents and adults: Manual. Psychological Corporation.
8.
BrownT. E.HoldnackJ.SaylorK.AdlerL.SpencerT.WilliamsD. W.PadivalA. K.SchuhK.TrzepaczP. T.KelseyD. (2011). Effect of atomoxetine on executive function impairments in adults with ADHD. Journal of Attention Disorders, 15(2), 130–138. https://doi.org/10.1177/1087054709356165
FayyadJ.De GraafR.KesslerR.AlonsoJ.AngermeyerM.DemyttenaereK.De GirolamoG.HaroJ. M.KaramE. G.LaraC.LepineJ. P.OrmelJ.Posada-VillaJ.ZaslavskyA. M.JinR. (2007). Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. British Journal of Psychiatry, 190(5), 402–409. https://doi.org/10.1192/bjp.bp.106.034389
11.
HeparkS.JanssenL.de VriesA.SchoenbergP. L. A.DondersR.KanC. C.SpeckensA. E. M. (2019). The efficacy of adapted MBCT on core symptoms and executive functioning in adults with ADHD: A preliminary randomized controlled trial. Journal of Attention Disorders, 23(4), 351–362. https://doi.org/10.1177/1087054715613587
12.
JainU.HechtmanL.WeissM.AhmedT. S.ReizJ. L.DonnellyG. A.HarsanyiZ.DarkeA. C. (2007). Efficacy of a novel biphasic controlled-release methylphenidate formula in adults with attention-deficit/hyperactivity disorder: Results of a double-blind, placebo-controlled crossover study. Journal of Clinical Psychiatry, 68(2), 268–277. https://doi.org/10.4088/jcp.v68n0213
13.
KesslerR. C.AdlerL.BarkleyR.BiedermanJ.ConnersC. K.DemlerO.FaraoneS. V.GreenhillL. L.HowesM. J.SecnikK.SpencerT.UstunT. B.WaltersE. E.ZaslavskyA. M. (2006). The prevalence and correlates of adult ADHD in the United States: Results from the national comorbidity survey replication. American Journal of Psychiatry, 163(4), 716–723. https://doi.org/10.1176/ajp.2006.163.4.716
14.
MarchantB. K.ReimherrF. W.RobisonR. J.OlsenJ. L.KondoD. G. (2011). Methylphenidate transdermal system in adult ADHD and impact on emotional and oppositional symptoms. Journal of Attention Disorders, 15(4), 295–304. https://doi.org/10.1177/1087054710365986
15.
MedoriR.Ramos-QuirogaJ. A.CasasM.KooijJ. J.NiemelaA.TrottG. E.LeeE.BuitelaarJ. K. (2008). A randomized, placebo-controlled trial of three fixed dosages of prolonged-release OROS methylphenidate in adults with attention-deficit/hyperactivity disorder. Biological Psychiatry, 63(10), 981–989. https://doi.org/10.1016/j.biopsych.2007.11.008
16.
PanM. R.HuangF.ZhaoM. J.WangY. F.WangY. F.QianQ. J. (2019). A comparison of efficacy between cognitive behavioral therapy (CBT) and CBT combined with medication in adults with attention-deficit/hyperactivity disorder (ADHD). Psychiatry Research, 279, 23–33. https://doi.org/10.1016/j.psychres.2019.06.040
17.
PolanczykG.de LimaM. S.HortaB. L.BiedermanJ.RohdeL. A. (2007). The worldwide prevalence of ADHD: A systematic review and metaregression analysis. American Journal of Psychiatry, 164(6), 942–948.
18.
ReimherrF. W.MarchantB. K.GiftT. E.SteansT. A.WenderP. H. (2015). Types of adult attention-deficit hyperactivity disorder (ADHD): Baseline characteristics, initial response, and long-term response to treatment with methylphenidate. Attention Deficit and Hyperactivity Disorders, 7(2), 115–128. https://doi.org/10.1007/s12402-015-0176-z
19.
ReimherrF. W.MarchantB. K.StrongR. E.HedgesD. W.AdlerL.SpencerT. J.WestS. A.SoniP. (2005). Emotional dysregulation in adult ADHD and response to atomoxetine. Biological Psychiatry, 58(2), 125–131. https://doi.org/10.1016/j.biopsych.2005.04.040
20.
ReimherrF. W.RoeslerM.MarchantB. K.GiftT. E.RetzW.Philipp-WiegmannF.ReimherrM. L. (2020). Types of adult attention-deficit/hyperactivity disorder: A replication analysis. The Journal of Clinical Psychiatry, 81(2), 21798.
21.
RetzW.RoslerM.OseC.ScheragA.AlmB.PhilipsenA.FischerR.AmmerR.StudyG. (2012). Multiscale assessment of treatment efficacy in adults with ADHD: A randomized placebo-controlled, multi-centre study with extended-release methylphenidate. World Journal of Biological Psychiatry, 13(1), 48–59. https://doi.org/10.3109/15622975.2010.540257
22.
RoslerM.RetzW.FischerR.OseC.AlmB.DeckertJ.PhilipsenA.HerpertzS.AmmerR. (2010). Twenty-four-week treatment with extended release methylphenidate improves emotional symptoms in adult ADHD. World Journal of Biological Psychiatry, 11(5), 709–718. https://doi.org/10.3109/15622971003624197
23.
RothR.IsquithP.GioiaG. (2005). Behavior rating inventory of executive function-adult version (BRIEF-A). Psychological Assessment Resources.
24.
SafrenS. A.OttoM. W.SprichS.WinettC. L.WilensT. E.BiedermanJ. (2005). Cognitive-behavioral therapy for ADHD in medication-treated adults with continued symptoms. Behaviour Research Therapy, 43(7), 831–842. https://doi.org/10.1016/j.brat.2004.07.001
25.
SilversteinM. J.FaraoneS. V.AlperinS.LeonT. L.BiedermanJ.SpencerT. J.AdlerL. A. (2019). Validation of the expanded versions of the adult ADHD self-report scale v1. 1 symptom checklist and the adult ADHD investigator symptom rating scale. Journal of Attention Disorders, 23(10), 1101–1110.
26.
SobanskiE.SabljicD.AlmB.BaehrC.DittmannR. W.SkoppG.Strohbeck-KuehnerP. (2012). A randomized, waiting list-controlled 12-week trial of atomoxetine in adults with ADHD. Pharmacopsychiatry, 45(3), 100–107. https://doi.org/10.1055/s-0031-1291319
27.
SurmanC. B.BiedermanJ.SpencerT.MillerC. A.McDermottK. M.FaraoneS. V. (2013). Understanding deficient emotional self-regulation in adults with attention deficit hyperactivity disorder: A controlled study. ADHD Attention Deficit and Hyperactivity Disorders, 5(3), 273–281.
28.
SurmanC. B.BiedermanJ.SpencerT.YorksD.MillerC. A.PettyC. R.FaraoneS. V. (2011). Deficient emotional self-regulation and adult attention deficit hyperactivity disorder: A family risk analysis. American Journal of Psychiatry, 168(6), 617–623.
29.
WeislerR.GinsbergL.DirksB.DeasP.AdeyiB.AdlerL. A. (2017). Treatment with lisdexamfetamine dimesylate improves self- and informant-rated executive function behaviors and clinician- and informant-rated ADHD symptoms in adults: Data from a randomized, double-blind, placebo-Controlled study. Journal of Attention Disorders, 21(14), 1198–1207. https://doi.org/10.1177/1087054713518242
30.
WenderP. H. (1998). Attention-deficit hyperactivity disorder in adults. Psychiatric Clinics of North America, 21(4), 761–774.
31.
WenderP. H.ReimherrF. W.MarchantB. K.SanfordM. E.CzajkowskiL. A.TombD. A. (2011). A one year trial of methylphenidate in the treatment of ADHD. Journal of Attention Disorders, 15(1), 36–45. https://doi.org/10.1177/1087054709356188
32.
WenderP. H.ReimherrF. W.WoodD.WardM. (1985). A controlled study of methylphenidate in the treatment of attention deficit disorder, residual type, in adults. The American Journal of Psychiatry, 142(5), 547–552.
33.
YoungS.EmilssonB.SigurdssonJ. F.KhondokerM.Philipp-WiegmannF.BaldurssonG.OlafsdottirH.GudjonssonG. (2017). A randomized controlled trial reporting functional outcomes of cognitive-behavioural therapy in medication-treated adults with ADHD and comorbid psychopathology. European Archives of Psychiatry and Clinical Neuroscience, 267(3), 267–276. https://doi.org/10.1007/s00406-016-0735-0
